1 October 2026
Hardide plc
("Hardide", the "Group" or the "Company")
Board Changes
As previously notified, Hardide plc (AIM: HDD), the provider of advanced surface treatment technology, confirms that, as part of the Group's new Leadership Team structure, Dr Yuri Zhuk has assumed the role of Chief Technology Officer with immediate effect, enabling him to focus exclusively on supporting the growth of the business, including product development, IP and operational excellence. In connection with this transition, Dr Zhuk has today stepped down as a director of the Company.
The Board would like to thank Dr Zhuk for his contribution as a director and looks forward to his continued leadership and contribution in his new role as Chief Technology Officer.
|
For further information: |
|
Hardide plc Matt Hamblin (CEO) Simon Hallam (Finance Director) |
Tel: +44 (0) 1869 353 830 |
Cavendish Capital Markets Ltd - Nominated Adviser and Broker Henrik Persson / Elysia Bough (Corporate Finance) Jasper Berry / Dale Bellis (Sales) |
Tel: +44 (0) 2072 200 500 |
IFC Advisory Graham Herring Tim Metcalfe |
Tel: +44 (0) 20 3934 6633 |
Notes to editors:
Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency as well as a reduced carbon footprint. Customers include leading companies operating in the energy sectors, valve and pump manufacturing, industrial gas turbine, precision engineering and aerospace industries.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.